Fayette J - Search Results

1

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.

Foy JP, Karabajakian A, Ortiz-Cuaran S, Boussageon M, Michon L, Bouaoud J, Fekiri D, Robert M, Baffert KA, Hervé G, Quilhot P, Attignon V, Girod A, Chaine A, Benassarou M, Zrounba P, Caux C, Ghiringhelli F, Lantuejoul S, Crozes C, Brochériou I, Pérol M, Fayette J, Bertolus C, Saintigny P. Foy JP, et al. Among authors: fayette j. Eur J Cancer. 2022 Oct;174:287-298. doi: 10.1016/j.ejca.2022.06.034. Epub 2022 Aug 26. Eur J Cancer. 2022. PMID: 36038492

2

Chemoprevention of lung cancer.

Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Soria JC, et al. Among authors: fayette j. Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0. Lancet Oncol. 2003. PMID: 14602246 Review.

3

[Chemoprevention in head and neck cancer and lung cancer].

Fayette J, Kiakouama L. Fayette J, et al. Bull Cancer. 2009;96 Suppl 1:S25-34. doi: 10.1684/bdc.2009.0785. Bull Cancer. 2009. PMID: 19433371 Review. French.

4

Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution.

Fayette J, Montella A, Chabaud S, Bachelot T, Pommier P, Girodet D, Racadot S, Montbarbon X, Favier B, Zrounba P. Fayette J, et al. Anticancer Drugs. 2010 Jun;21(5):553-8. doi: 10.1097/CAD.0b013e3283388e60. Anticancer Drugs. 2010. PMID: 20220515

5

Current chemotherapies for recurrent/metastatic head and neck cancer.

Molin Y, Fayette J. Molin Y, et al. Among authors: fayette j. Anticancer Drugs. 2011 Aug;22(7):621-5. doi: 10.1097/CAD.0b013e3283421f7c. Anticancer Drugs. 2011. PMID: 21131821 Review.

6

Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma.

Péron J, Ceruse P, Lavergne E, Buiret G, Pham BN, Chabaud S, Favier B, Girodet D, Zrounba P, Ramade A, Fayette J. Péron J, et al. Among authors: fayette j. Anticancer Drugs. 2012 Oct;23(9):996-1001. doi: 10.1097/CAD.0b013e32835507e5. Anticancer Drugs. 2012. PMID: 22643048

7

Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma.

Péron J, Poupart M, Ceruse P, Ramade A, Girodet D, Zrounba P, Fayette J. Péron J, et al. Among authors: fayette j. Anticancer Drugs. 2012 Nov;23(10):1107-11. doi: 10.1097/CAD.0b013e328358d226. Anticancer Drugs. 2012. PMID: 22954504

8

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.

el Sayadi H, Pissaloux D, Alberti L, Tabone-Eglinger S, Ranchere D, Decouvelaere AV, Tabone E, Ray-Coquard I, Caux C, Fayette J, Blay JY. el Sayadi H, et al. Among authors: fayette j. Target Oncol. 2013 Dec;8(4):261-9. doi: 10.1007/s11523-012-0249-2. Epub 2013 Jan 25. Target Oncol. 2013. PMID: 23354874

9

Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.

Fayette J, Bonnin N, Ferlay C, Lallemant B, Ramade A, Favrel V, Zrounba P, Chabaud S, Pommier P, Poupart M, Céruse P. Fayette J, et al. Anticancer Drugs. 2013 Jul;24(6):623-9. doi: 10.1097/CAD.0b013e328360b9d6. Anticancer Drugs. 2013. PMID: 23542750

10

[Identification of occupational exposures among patients with lung cancer].

Cellier C, Charbotel B, Carretier J, Rebattu P, Fayette J, Pérol M, Claude L, Philip T, Fervers B. Cellier C, et al. Among authors: fayette j. Bull Cancer. 2013 Jul-Aug;100(7-8):661-70. doi: 10.1684/bdc.2013.1783. Bull Cancer. 2013. PMID: 23831888 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters